TipRanks
Advertisement
Advertisement

HK:2591 Stock Latest News

Guangzhou Innogen Strengthens Commercial Leadership With New Vice President Appointment
Company AnnouncementsGuangzhou Innogen Strengthens Commercial Leadership With New Vice President Appointment
5d ago
2591
Guangzhou Innogen Pharma Announces Board Resignations and Strategy Committee Change
PremiumCompany Announcements
Guangzhou Innogen Pharma Announces Board Resignations and Strategy Committee Change
8d ago
2591
Guangzhou Innogen Sets Out Board Structure and Committee Roles
PremiumCompany Announcements
Guangzhou Innogen Sets Out Board Structure and Committee Roles
8d ago
2591
Innogen Pharma Founder and Executives Extend Share Lock-Up to Signal Confidence
PremiumCompany Announcements
Innogen Pharma Founder and Executives Extend Share Lock-Up to Signal Confidence
2M ago
2591
Guangzhou Innogen Pharmaceutical Launches HK$50 Million H-Share Buyback Plan
PremiumCompany Announcements
Guangzhou Innogen Pharmaceutical Launches HK$50 Million H-Share Buyback Plan
2M ago
2591
Innogen ramps Efsubaglutide push as losses persist in first NRDL year
PremiumCompany AnnouncementsInnogen ramps Efsubaglutide push as losses persist in first NRDL year
2M ago
2591
Guangzhou Innogen Schedules Board Meeting to Review 2026 Interim Results and Dividend Plan
Premium
Company Announcements
Guangzhou Innogen Schedules Board Meeting to Review 2026 Interim Results and Dividend Plan
2M ago
2591
Guangzhou Innogen Gains PIC/S GMP Approval for Efsubaglutide Manufacturing Sites
Premium
Company Announcements
Guangzhou Innogen Gains PIC/S GMP Approval for Efsubaglutide Manufacturing Sites
3M ago
2591
Guangzhou Innogen Starts Phase Ib Trial of Adolescent Obesity Drug Efsubaglutide Alfa
PremiumCompany Announcements
Guangzhou Innogen Starts Phase Ib Trial of Adolescent Obesity Drug Efsubaglutide Alfa
3M ago
2591
Guangzhou Innogen Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany Announcements
Guangzhou Innogen Wins Strong Shareholder Backing at 2026 AGM
4M ago
2591
Guangzhou Innogen Sets Formal Audit Committee Mandate to Strengthen Governance
PremiumCompany Announcements
Guangzhou Innogen Sets Formal Audit Committee Mandate to Strengthen Governance
4M ago
2591
Guangzhou Innogen Wins NMPA Nod for Adolescent Obesity Trial
PremiumCompany Announcements
Guangzhou Innogen Wins NMPA Nod for Adolescent Obesity Trial
4M ago
2591
Guangzhou Innogen Sets 2026 AGM to Approve 2025 Results and Board Re-elections
PremiumCompany AnnouncementsGuangzhou Innogen Sets 2026 AGM to Approve 2025 Results and Board Re-elections
5M ago
2591
Guangzhou Innogen Proposes New Share Award Scheme to Strengthen Incentives
Premium
Company Announcements
Guangzhou Innogen Proposes New Share Award Scheme to Strengthen Incentives
5M ago
2591
Guangzhou Innogen Seeks Board Re-Election and Governance Updates
Premium
Company Announcements
Guangzhou Innogen Seeks Board Re-Election and Governance Updates
5M ago
2591
Innogen Deepens Metabolic Focus as Efsubaglutide Launch Drives First Revenue but Widens Loss
PremiumCompany Announcements
Innogen Deepens Metabolic Focus as Efsubaglutide Launch Drives First Revenue but Widens Loss
7M ago
2591
Guangzhou Innogen Reshapes Company Secretariat and Secures HKEX Compliance Waiver
PremiumCompany Announcements
Guangzhou Innogen Reshapes Company Secretariat and Secures HKEX Compliance Waiver
7M ago
2591
Guangzhou Innogen Warns of Wider 2025 Loss Despite Revenue From New Diabetes Drug
PremiumCompany Announcements
Guangzhou Innogen Warns of Wider 2025 Loss Despite Revenue From New Diabetes Drug
7M ago
2591
Guangzhou Innogen Seeks Full H-Share Circulation via Conversion of Domestic Shares
PremiumCompany Announcements
Guangzhou Innogen Seeks Full H-Share Circulation via Conversion of Domestic Shares
7M ago
2591
Guangzhou Innogen Pharma Reshapes Company Secretarial Team with New Joint Appointment and Listing Rules Waiver
PremiumCompany AnnouncementsGuangzhou Innogen Pharma Reshapes Company Secretarial Team with New Joint Appointment and Listing Rules Waiver
9M ago
2591
Guangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa
Premium
Company Announcements
Guangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa
9M ago
2591
Guangzhou Innogen Updates Corporate Articles Following H Share Listing
Premium
Company Announcements
Guangzhou Innogen Updates Corporate Articles Following H Share Listing
10M ago
2591

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >